The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions

¹Institute of Human Physiology, University of Palermo, Italy.

|March 15, 2000

Abstract:

The present experiments were designed to extend previous work showing that acute intermittent (-)nicotine treatment upregulates the level of fibroblast growth factor-2 (FGF2) mRNA in several rat brain regions, by the use of the nicotinic acetylcholine receptor (nAChR) agonist ABT-594 with preferential selectivity for the alpha4beta2 nAChR subtype. ABT594 treatment led to a well-defined temporal and regional upregulation of FGF-2 mRNA. A double labelling analysis showed that the up-regulation of FGF-2 mRNA involves both neuronal and non-neuronal cells. The effects of ABT-594 on FGF-2 expression were antagonized by the preferential alpha4beta2 antagonist dihydrobetaerythroidine (DHbetaE), but not by alpha7 antagonist methyllycaconitine (MLA). In conclusion, FGF-2 mRNA levels can be increased in several brain regions upon alpha4beta2 nAChR activation, suggesting a therapeutic significance in neurodegenerative disorders.

Related Experiment Videos

The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions

Related Concept Videos

Existence of muscarinic acetylcholine receptor (mAChR) and fibroblast growth factor receptor (FGFR) heteroreceptor complexes and their enhancement of neurite outgrowth in neural hippocampal cultures.

Recovery of damaged skeletal muscle in mdx mice through low-intensity endurance exercise.

Group II metabotropic glutamate receptor activation by agonist LY379268 treatment increases the expression of brain derived neurotrophic factor in the mouse brain.

The FGF-2/FGFRs neurotrophic system promotes neurogenesis in the adult brain.

Regulation of connexin gene expression during skeletal muscle regeneration in the adult rat.

Acute intermittent nicotine treatment induces fibroblast growth factor-2 in the subventricular zone of the adult rat brain and enhances neuronal precursor cell proliferation.

Maresin 1 delivered via a poly(lactic-co-glycolic acid) conduit enhances sciatic nerve regeneration in rats and is associated with glycogen synthase kinase-3β/β-catenin signaling.

Involvement of phosphorylated caveolin-1 in the dorsal root ganglion in diabetic neuropathic pain and the interventional effect of electroacupuncture.

Biophysical characterization of Arc protein-RNA interactions.

Olig2 downregulation mitigates early neurological deficits by modulating mitochondrial dynamics in neonatal hypoxic-ischemic brain injury.

Low-dose N-methyl-D-aspartate protects against amyloid-β-induced neurotoxicity by suppressing the MLK3-MKK7-JNK3 pathway and activating the PI3K-PDK1-Akt pathway.

Melatonin attenuates ferroptosis-associated injury through modulation of the thioredoxin-interacting protein/thioredoxin-1/glutathione peroxidase 4 pathway after neonatal hypoxic ischemic brain damage.

Antrochoanal Polyps: Nasal Anatomical and Pathological Variants as Risk Factors.

Multimodal MRI Radiomics and Machine Learning Identify Node-Level Structural and Functional Alterations in HIV-Associated Asymptomatic Neurocognitive Impairment.

Autophagy-lysosomal pathway in neurodegeneration.

Energetic analysis of Na+/K+-ATPase using bond graphs.

Related Experiment Videos

The nicotinic acetylcholine receptor agonist ABT-594 increases FGF-2 expression in various rat brain regions

Abstract:

Related Concept Videos

Related Articles